Good Karma in Biotech and Pharma
American pharmaceutical giant Eli Lilly is radically expanding its presence in Germany.
That’s great news for the country, which sees biotech and pharmaceuticals as one of its
main pillars for the years to come.
Your company is already operating in Germany and you would now like to export worldwide?
American pharmaceutical giant Eli Lilly is radically expanding its presence in Germany.
That’s great news for the country, which sees biotech and pharmaceuticals as one of its
main pillars for the years to come.
Germany’s healthcare sector enjoyed a successful year with a resurgent biotech sector generating a quarter of new capital. New therapies are being developed for a range of autoimmune diseases and telemedicine service are on the rise.
The injectable Mounjaro that will be mass produced by Eli Lilly and Company in Germany has been cleared for use in helping people shed pounds.
In 2023, there was a notable resurgence in the financing available to Germany's biotechnology sector.
MEDICA 2023, the world-leading information and communication platform for the medical technology industry and supplier industry took place in November.
Innovative start-ups are booming in Germany's attractive life sciences sector.
Therapeutics and autonomous driving, recycling and space junk, are all part of our regular survey of some of the most interesting developments in German research and development.
A quartet of young German companies have secured nine-figure financing rounds. Here’s our bimonthly round-up of some of the largest venture-capital deals in Germany.
Germany's research and development (R&D) landscape is second to none in the EU- whether it be practical, theoretical or industrial research. Here’s a round of some of the latest R&D breakthroughs “Made in Germany.”
Germany's life sciences sector is proving attractive to start-up investors and international health companies alike.